• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Patricia Coyle, MD, Discusses Diagnostic Tools Utilized in Multiple Sclerosis

Article

In this video, Patricia Coyle, MD, director, MS Comprehensive Care Center, Stony Brook Neurosciences Institute, professor and vice chair of clinical affairs, Department of Neurology, SUNY at Stony Brook, emphasized the need to establish biomarkers for the treatment of multiple sclerosis.

In this video, Patricia Coyle, MD, director, MS Comprehensive Care Center, Stony Brook Neurosciences Institute, professor and vice chair of clinical affairs, Department of Neurology, SUNY at Stony Brook, emphasized the need to establish biomarkers for the treatment of multiple sclerosis. Dr Coyle said that the best biomarkers for disease activity available are in neuroimaging with T1 and T2-based MRI measures. There are also nonconventional techniques used that can image microscopic damage. Dr Coyle notes that these techniques are not used routinely clinically, but expects it will be used more and more.

“There is no single diagnostic test for MS.” “We need even more sensitive disease activity for biomarkers,” said Dr Coyle.

Related Videos
Michael David Chuong, MD, radiation oncologist, Miami Cancer Institute, Baptist Health South Florida
Yuman Fong, MD, cancer surgeon, City of Hope
Elena Elimova, MD, associate professor in the Department of Medicine at the University of Toronto and staff medical oncologist at Princess Margaret Hospital
Dr Eric Yang
Enrique Velazquez Villarreal, MD, PhD, MPH, MS, assistant professor in the department of integrative translational sciences at City of Hope
Dr Steven Manobianco
Dr Amrita Basu
Dr Eric Yang
Dr Adam Brufsky
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.